The ongoing COVID-19 pandemic has been significantly concerning for many of us. Our understanding of the virus is constantly evolving, as are the guidelines for how we can best protect ourselves and our loved ones. With that in mind, we wanted to give community members an opportunity to have their questions answered by a specialist.

On March 23rd, we held a webinar hosted by Dr. Carl B. Lauter, MD, an Allergy & Immunology and Infectious Disease specialist at Beaumont Hospital in Michigan. Among the topics discussed were...

  • What we know about COVID-19
  • What we can expect in the coming weeks
  • Best practices for preventing the spread of COVID-19
  • What steps you can take to keep yourself and your loved ones safe

ABOUT THE PRESENTER — DR. CARL B. LAUTER, MD
Dr. Carl B. Lauter, MD is an allergist-immunologist and infectious disease specialist with more than 50 years’ experience, and he is affiliated with Beaumont Hospital–Royal Oak in Michigan. He obtained his medical degree from Wayne State University School of Medicine.

Dr. Lauter’s internal medicine residency was at the Hospital of the University of Pennsylvania. He completed his training with an Infectious Disease fellowship at Detroit Medical Center, followed by an Allergy & Immunology fellowship at the Henry Ford Hospital.

PAST PERFORMANCE IS NOT A GUARANTEE OF FUTURE RESULTS. This commentary is a matter of opinion and is for informational purposes only. It is not intended as investment advice and does not address or account for individual investor circumstances. Investment decisions should always be made based on the client's specific financial needs, goals and objectives, time horizon and risk tolerance. The statements contained herein are based solely upon the opinions of Telemus Capital, LLC. All opinions and views constitute our judgments as of the date of writing and are subject to change at any time without notice. Information was obtained from third party sources, which we believe to be reliable, but not guaranteed.

New call-to-action
New Call-to-action